Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthequity (HQY) Other Operating Expenses (2016 - 2026)

Healthequity has reported Other Operating Expenses over the past 14 years, most recently at $51.9 million for Q1 2026.

  • For Q1 2026, Other Operating Expenses rose 3.56% year-over-year to $51.9 million; the TTM value through Jan 2026 reached $203.2 million, changed 0.28%, while the annual FY2026 figure was $203.2 million, 0.28% changed from the prior year.
  • Other Operating Expenses for Q1 2026 was $51.9 million at Healthequity, up from $51.4 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $53.0 million in Q2 2025 and troughed at $38.6 million in Q1 2022.
  • A 5-year average of $45.9 million and a median of $43.8 million in 2024 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: rose 26.44% in 2022 and later dropped 10.63% in 2025.
  • Year by year, Other Operating Expenses stood at $41.2 million in 2022, then grew by 3.93% to $42.9 million in 2023, then grew by 18.93% to $51.0 million in 2024, then increased by 0.84% to $51.4 million in 2025, then grew by 0.89% to $51.9 million in 2026.
  • Business Quant data shows Other Operating Expenses for HQY at $51.9 million in Q1 2026, $51.4 million in Q4 2025, and $46.9 million in Q3 2025.